欢迎登录材料期刊网

材料期刊网

高级检索

聚氯乙烯( PVC)材质的医疗器械产品中需要加入增塑剂以改善柔韧性,目前最常用的增塑剂是邻苯二甲酸二(2-乙基)己酯(DEHP)和偏苯三酸三辛酯(TOTM)。本文考察了 PVC一次性使用输液器产品在脂溶性药液(紫杉醇注射液)、肠外营养液(脂肪乳)、酸性药液(左氧氟沙星,pH 3.0~5.0)和碱性药液(呋塞米,pH 8.0~9.0)中的DEHP和 TOTM溶出量,并进行对比分析。先建立了一种高效液相色谱-紫外检测( HPLC-UV)方法测定增塑剂的溶出量,并利用该方法对增塑剂的溶出量进行了分析。实验结果表明,增塑剂在不同药液中均有一定的溶出情况,其中紫杉醇注射液对增塑剂的溶出量要高于脂肪乳,并远高于左氧氟沙星和呋塞米注射液。通过对比 DEHP 和TOTM的溶出量可以看出,在相同的浸提条件下,TOTM 的溶出量远低于 DEHP 的溶出量。利用紫杉醇注射液浸提24 h,PVC输液器产品 DEHP 的溶出量为21.14 mg,而 TOTM 的溶出量仅为0.078 mg。DEHP 的溶出量为TOTM溶出量的270倍。因此,TOTM具有的较好耐迁移性,是一种潜在的 DEHP替代增塑剂。

Polyvinyl-chloride(PVC)with plasticizers of di(2-ethylhexyl)phthalate(DEHP)and tris(2-ethyl-hexyl)trimellitate( TOTM)is widely used in medical and paramedical appliances. However,such plasticizers can leach from PVC products into contact solutions. The aim of this study is to investigate the release behaviors of DEHP and TOTM from the PVC intravenous infusion set into various pharmaceutical solutions under the sim-ulated clinical conditions,such as the lipophilic substances( paclitaxel),parenteral nutrition( fat emulsion injection),acid and alkali pharmaceutical solution( levofloxacin hydrochloride injection,pH 3. 0-5. 0 and furo-semide,pH 8. 0-9. 0). A simple and rapid high-performance liquid chromatographic method with UV detection ( HPLC-UV)for the determination of DEHP or TOTM released from PVC medical devices into the above intrave-nous preparations was developed. The cumulative amounts of DEHP or TOTM released in 24 h were in the same following order:paclitaxel>fat emulsion injection>levofloxacin hydrochloride> furosemide solution. From a comparison of the cumulative amounts of released DEHP and TOTM from the above solutions,we found that the cumulative amount of TOTM is far less than that of DEHP,under the same conditions. The cumulative amount of the DEHP released in 24 h in the paclitaxel solution was 21. 14 mg,while under the same conditions, the cumulative amount of TOTM was only 0. 078 mg. The cumulative amount of DEHP is assumed to be about 270 times that of the released TOTM. Thus TOTM could be a superior alternative to DEHP for use in medical de-vices because of its potential lower leachability.

参考文献

[1] Bernard L;Cueff R;Bourdeaux D.[J].Anal Bioanal Chem,2015407:1651.
[2] Wu W;Hu J;Wang J.[J].Sci Total Environ,2015508:445.
[3] Kambia K;Dine T;Azar R;Gressier B;Luyckx M;Brunet C.Comparative study of the leachability of di(2-ethylhexyl) phthalate and tri(2-ethylhexyl) trimellitate from haemodialysis tubing.[J].International Journal of Pharmaceutics,20011/2(1/2):139-146.
[4] Kambia K;Dine T;Gressier B.[J].J Chromatogr B,2001755:297.
[5] Xu D M;Deng X J;Fang E H.[J].J Chromatogr A,20141324:49.
[6] Wang M L;Kou L J;Zhang Y Q.[J].Chinese Journal of Chromatography,200725(4):577.
[7] Lai Y;Huang Z P;Ge X X.[J].Chinese Journal of Chro-matography,201230(7):647.
[8] Liu P Y;Gao L;Shen J.[J].Chinese Journal of Chroma-tography,201028(5):517.
[9] Xu X H;Yang Y L;Wang R.[J].Chemosphere,2015124:22.
[10] Heudorf U;Mersch-Sundermann V;Angerer J.[J].Int J Hyg Environ Health,2007210:623.
[11] Lin Y;Min L;Huang Q S.[J].Environ Toxicol,201530(2):197.
[12] European Union .Directive 2007/47/EC of the European Parliament and of the Council of 5 September 2007 Amen-ding Council Directive 90/385/EEC on the Approximation of the Laws of the Member States Relating to Active Im-plantable Medical Devices,Council Directive 93/42/EEC Concerning Medical Devices and Directive 98/8/EC Con-cerning the Placing of Biocidal Products on the Market[OL].http://eur-lex.europa.eu/legal-content/en/ALL/?uri=CELEX:32007L0047,2007-09-05.
[13] Bernard L;Decaudin B;Lecoeur M.[J].Talanta,2014129:39.
[14] Wang H H;Chen K;Lin C.[J].Vox Sanguinis,2013105:143.
[15] Chiera A O;Rimorini L;Krause L E.[J].Vox Sanguinis,2012103:270.
[16] Ito R;Miura N;Iguchi H;Nakamura H;Ushiro M;Wakui N;Nakahashi K;Iwasaki Y;Saito K;Suzuki T;Nakazawa H.Determination of tris(2-ethylhexyl)trimellitate released from PVC tube by LC-MS/MS.[J].International Journal of Pharmaceutics,20081/2(1/2):91-95.
[17] Loff S;Kabs F;Witt K;Sartoris J;Mandl B;Niessen KH;Waag KL.Polyvinylchloride infusion lines expose infants to large amounts of toxic plasticizers.[J].Journal of Pediatric Surgery: Official Journal of the Surgical Section of the American Academy of Pediatric, the British Association of Paediatric Surgeons, the American Pediatric Surgical Association, and the Canadian Association of Paediatric Surgeons,200012(12):1775-1781.
[18] Takehisa H;Naoko E;Masahiko S;Katsuhide T;Moriyuki O;Keizoh S;Mutsuko T;Kenji K;Shin'ichiro N;Toshio O.Release behavior of diethylhexyl phthalate from the polyvinyl-chloride tubing used for intravenous administration and the plasticized PVC membrane.[J].International Journal of Pharmaceutics,20051/2(1/2):30-37.
[19] Welle F;Wolz G;Franz R.[J].Forschung und Entwicklung,20053:17.
[20] Genay S;Luciani C;Decaudin B;Kambia N;Dine T;Azaroual N;Di Martino P;Barthelemy C;Odou P.Experimental study on infusion devices containing polyvinyl chloride: to what extent are they di(2-ethylhexyl)phthalate-free?[J].International Journal of Pharmaceutics,20111/2(1/2):47-51.
上一张 下一张
上一张 下一张
计量
  • 下载量()
  • 访问量()
文章评分
  • 您的评分:
  • 1
    0%
  • 2
    0%
  • 3
    0%
  • 4
    0%
  • 5
    0%